BackInterpace Biosciences Overview
Interpace Biosciences, Inc.

Interpace Biosciences Return on Equity

Valuation check: IDXG's ROE is 105.18%, above the sector sector average of 11.85%.

Get informed when a big investor buys or sells

+ Follow

ROE

105.18%

Return on Equity

105.18%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

Interpace Biosciences (IDXG) FAQ

As of the most recent data, IDXG shows a ROE of 105.18%. That is above the sector sector average of 11.85%. Scroll down for historical charts and peer comparison views.

The its sector sector average ROE is about 11.85%. Interpace Biosciences is at 105.18%, which is higher that average. That is roughly 787.4% above the sector mean. Use the comparison chart on this page to see how IDXG stacks up against individual peers as well.

Check the historical chart to see whether IDXG's ROE is trending up or down. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Interpace Biosciences with peers to see if the move is company-specific or sector-wide.

Besides this return on equity page, Stockcircle has Interpace Biosciences's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect ROE (currently 105.18%) with ownership activity and broader fundamentals.